RT Book, Section
A1 HODGMAN, TUDY
A2 Cohen, Henry
SR Print(0)
ID 1112257605
T1 Lidocaine
T2 Casebook in Clinical Pharmacokinetics and Drug Dosing
YR 2015
FD 2015
PB McGraw-Hill Education
PP New York, NY
SN 9780071628358
LK accesspharmacy.mhmedical.com/content.aspx?aid=1112257605
RD 2024/04/18
AB Lidocaine  is  a  local  anesthetic  that  also  has  Vaughan  Williams  classification  type  IB  antiarrhythmic  properties.  It  is  indicated  for  ventricular  fibrillation  in  patients  who  cannot  undergo  synchronized  cardioversion  and  are  hemodynamically  stable  who  do  not  require  electrical  cardioversion.  It  can  also  be  used  for  both  monomorphic  and  polymorphic  ventricular  tachycardias.  Lidocaine  is  considered  an  alternative  to  amiodarone  as  a  second-line  agent  in  patients  with  ventricular  tachycardia  or  pulseless  electrical  activity  who  are  resistant  to  electric  cardioversion  and  intravenous  epinephrine  or  vasopressin.1  The  use  of  intravenous  lidocaine  has  decreased  with  the  elimination  of  lidocaine  as  the  standard  of  practice  for  prophylaxis  of  asymptomatic  premature  ventricular  contractions  or  nonsustained  ventricular  tachycardia  after  acute  myocardial  infarction.